Nov 25, 2021 07:39 PM (GMT+8) · EqualOcean
Cailian news agency, Nov. 25 - Meikang biology announced that the company plans to jointly initiate the establishment of XX biomedical health equity investment partnership (limited partnership) with Qixia capital, focusing on the biomedical health industry. The scale of the fund is 700 million yuan, including 500 million yuan subscribed by Meikang biology and 200 million yuan subscribed by other limited partners. The term of the fund is 8 years.